T1	Participants 68 103	adult respiratory distress syndrome
T2	Participants 336 424	G-CSF group which received chemotherapy with G-CSF and historical controls without G-CSF
T3	Participants 439 481	132 patients with hematological malignancy
T4	Participants 1019 1031	G-CSF group,
T5	Participants 1200 1204	ARDS
T6	Participants 1811 1822	G-CSF group
